Bukwang Pharm Capital Reinvestment Ratio
Bukwang Pharm capital reinvestment ratio. Bukwang Pharm (003000) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.03 Billion) in capital expenditures (₩2.80 Billion). Check Bukwang Pharm (003000) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bukwang Pharm (2007–2024)
Capital reinvestment ratio of Bukwang Pharm from 2007 to 2024. This chart tracks Bukwang Pharm's Capital Reinvestment Ratio across 10 annual periods. Also explore how fast is Bukwang Pharm growing its equity to track the company's year-over-year net asset growth rate.
Bukwang Pharm Capital Reinvestment Ratio by Year (2007–2024)
Bukwang Pharm capital reinvestment ratio by year from 2007 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Bukwang Pharm.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | ₩34.36 Billion | ₩2.61 Billion | ▼ -74.9% |
| 2022 | 0.30x | ₩16.46 Billion | ₩4.99 Billion | ▲ +924.3% |
| 2021 | 0.03x | ₩26.52 Billion | ₩785.05 Million | ▼ -98.9% |
| 2020 | 2.65x | ₩723.17 Million | ₩1.92 Billion | ▲ +387.4% |
| 2018 | 0.54x | ₩6.82 Billion | ₩3.71 Billion | ▲ +3.8% |
| 2017 | 0.52x | ₩8.56 Billion | ₩4.49 Billion | ▲ +17.8% |
| 2015 | 0.44x | ₩10.30 Billion | ₩4.58 Billion | ▲ +317.6% |
| 2014 | 0.11x | ₩27.86 Billion | ₩2.97 Billion | ▲ +3.8% |
| 2013 | 0.10x | ₩36.52 Billion | ₩3.74 Billion | ▼ -86.2% |
| 2007 | 0.74x | ₩27.87 Billion | ₩20.69 Billion | — |